Skip to content
★ Sign in to follow
Nova Eye Medical Limited logo

Nova Eye Medical Limited Stock: price and insider trades · Australia

ISIN AU0000094252AU·Mcap A$41.3MHealth Care

1 insider bought shares over the last 90 days, the latest by Thomas Anthony Spurling, filed 28 Aug 2026.

Nova Eye Medical Limited: what insiders have been doing

This page follows insider dealings at Nova Eye Medical Limited as filed with ASX, a company from the Health Care sector. Between 5 November 2025 and 5 November 2026, 3 insiders published 3 filings.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 senior executive.

The last insider purchase was made public on 28 August 2026, 72 days ago.

Across the 1,622 companies tracked on its exchange, the median is 5 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2026, counts 1 purchase against no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from ASX. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Thomas Anthony Spurling1 buy
Fundamental score
Ranked 22,771 of 26,911 companies
26.9
score / 100
Value
17
Quality
37
FCF yld-8.9%
Earn yld-11%
EV/EBITDA·
ROE-26%
Gross mgn72%
Net mgn-12%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.15
Analyst consensus
2 analysts
2.00/5
A$0.33Target A$0.43(+193%)A$0.52
Income statement
RevenueA$34.9M
Gross profitA$25M72% margin
EBITDA-A$4.4M-13% margin
Net income-A$4.3M-12.4% margin
Valuation
PER (forward)18.1x
P/Book2.9x
Beta0.93
Balance sheet & cash
Market capA$41.3M
Total debtA$2.4M
Free Cash Flow-A$3.5M
Debt / Equity17%
Profitability & ownership
ROE-26.1%
ROA-11.4%
% insiders18.9%
% institutions18.2%
Last declaration on 5 November 2026
Declarations3 total
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXISIN AU0000094252ASX:2924-03158362-2A1708544
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXASX:2924-03156012-2A1707280
  • ▲
    DirectorExecutives
    0ASX
    160,000 sharesShareASXASX:2924-03128377-2A1693286
    Canonical exit: 25 Nov 2026 (T+90)

3 of 3 declarations

About Nova Eye Medical Limited

EYE is a company listed on the XASX. It specializes in the information technology sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations